Targeting steroid receptor co-activators to inhibit breast cancer stem cells
Oncoscience
.
2018 Aug 28;5(11-12):281-282.
doi: 10.18632/oncoscience.469.
eCollection 2018 Nov.
Authors
Thu H Truong
1
,
Carol A Lange
1
,
Julie H Ostrander
1
Affiliation
1
Departments of Medicine (Division of Hematology, Oncology, and Transplantation) and Pharmacology, Masonic Cancer Center, University of Minnesota, Minneapolis MN 55455 USA.
PMID:
30652114
PMCID:
PMC6326735
DOI:
10.18632/oncoscience.469
No abstract available
Keywords:
AIB1; PELP1; SRC-3; breast cancer; cancer stem cells.
Grants and funding
F32 CA210340/CA/NCI NIH HHS/United States
T32 HL007741/HL/NHLBI NIH HHS/United States